Presented by: University of Kentucky Department of Pathology

“ What we learn from tradition FISH in the diagnosis of Ewing Sarcoma.”

      Drs Theresa Bocklage and Sainan Wei, MD

Thursday, February 5, 2026

12:00 – 1:00pm

In-Person MS 147 or Zoom: 

 https://us06web.zoom.us/j/87832764787?pwd=Rgj3iqV6y29XzBe783LTI1Y8Nvwt5g.1

Please sign-in with first, last name and credentials

At the completion of this lecture attendees should be able to:

• Define Ewing Sarcoma​
• Categorize the clinical presentation, imaging findings and disease course​
• Outline the pathophysiology of ES​
• Compare the tumor differential, e.g., histologic, IHC and molecular findings in other tumors histologically mimicking ES​
• Provide examples of the new therapies for ES
• Discuss the genetic diagnostic methods in work-up of possible ES

Disclosure of Financial Interest Summary to Learners
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.
Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation